rs4987047

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000059.4(BRCA2):​c.8830A>T​(p.Ile2944Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00217 in 1,613,882 control chromosomes in the GnomAD database, including 73 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I2944M) has been classified as Uncertain significance. The gene BRCA2 is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.012 ( 38 hom., cov: 33)
Exomes 𝑓: 0.0012 ( 35 hom. )

Consequence

BRCA2
NM_000059.4 missense

Scores

4
10

Clinical Significance

Benign reviewed by expert panel U:2B:36O:1

Conservation

PhyloP100: 1.12

Publications

41 publications found
Variant links:
Genes affected
BRCA2 (HGNC:1101): (BRCA2 DNA repair associated) Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020]
BRCA2 Gene-Disease associations (from GenCC):
  • BRCA2-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • breast-ovarian cancer, familial, susceptibility to, 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • Fanconi anemia complementation group D1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics
  • pancreatic cancer, susceptibility to, 2
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • sarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • hereditary breast ovarian cancer syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • medulloblastoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006045282).
BP6
Variant 13-32379392-A-T is Benign according to our data. Variant chr13-32379392-A-T is described in ClinVar as Benign. ClinVar VariationId is 41569.Status of the report is reviewed_by_expert_panel, 3 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0117 (1779/152306) while in subpopulation AFR AF = 0.0409 (1698/41562). AF 95% confidence interval is 0.0392. There are 38 homozygotes in GnomAd4. There are 823 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 38 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000059.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCA2
NM_000059.4
MANE Select
c.8830A>Tp.Ile2944Phe
missense
Exon 22 of 27NP_000050.3A0A7P0T9D7
BRCA2
NM_001432077.1
c.8830A>Tp.Ile2944Phe
missense
Exon 22 of 27NP_001419006.1A0A7P0T9D7
BRCA2
NM_001406720.1
c.8830A>Tp.Ile2944Phe
missense
Exon 22 of 27NP_001393649.1A0A8V8TPZ2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCA2
ENST00000380152.8
TSL:5 MANE Select
c.8830A>Tp.Ile2944Phe
missense
Exon 22 of 27ENSP00000369497.3P51587
BRCA2
ENST00000544455.6
TSL:1
c.8830A>Tp.Ile2944Phe
missense
Exon 22 of 27ENSP00000439902.1P51587
BRCA2
ENST00000530893.7
TSL:1
c.8461A>Tp.Ile2821Phe
missense
Exon 22 of 27ENSP00000499438.2A0A590UJI7

Frequencies

GnomAD3 genomes
AF:
0.0116
AC:
1769
AN:
152188
Hom.:
38
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0407
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00367
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00814
GnomAD2 exomes
AF:
0.00295
AC:
740
AN:
250828
AF XY:
0.00204
show subpopulations
Gnomad AFR exome
AF:
0.0415
Gnomad AMR exome
AF:
0.00154
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000265
Gnomad OTH exome
AF:
0.00131
GnomAD4 exome
AF:
0.00118
AC:
1722
AN:
1461576
Hom.:
35
Cov.:
31
AF XY:
0.00101
AC XY:
732
AN XY:
727086
show subpopulations
African (AFR)
AF:
0.0425
AC:
1423
AN:
33462
American (AMR)
AF:
0.00206
AC:
92
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26124
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39654
South Asian (SAS)
AF:
0.000128
AC:
11
AN:
86200
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53412
Middle Eastern (MID)
AF:
0.00243
AC:
14
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000198
AC:
22
AN:
1111876
Other (OTH)
AF:
0.00265
AC:
160
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
94
188
281
375
469
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0117
AC:
1779
AN:
152306
Hom.:
38
Cov.:
33
AF XY:
0.0110
AC XY:
823
AN XY:
74494
show subpopulations
African (AFR)
AF:
0.0409
AC:
1698
AN:
41562
American (AMR)
AF:
0.00366
AC:
56
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5194
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000118
AC:
8
AN:
68018
Other (OTH)
AF:
0.00806
AC:
17
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
86
173
259
346
432
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00193
Hom.:
5
Bravo
AF:
0.0138
ESP6500AA
AF:
0.0411
AC:
181
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00377
AC:
458
Asia WGS
AF:
0.00202
AC:
7
AN:
3478
EpiCase
AF:
0.000164
EpiControl
AF:
0.00

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
9
Breast-ovarian cancer, familial, susceptibility to, 2 (10)
-
-
9
not specified (10)
-
-
5
not provided (5)
-
-
4
Hereditary breast ovarian cancer syndrome (4)
-
-
4
Hereditary cancer-predisposing syndrome (4)
-
-
2
Familial cancer of breast (2)
-
-
1
BRCA2-related cancer predisposition (1)
-
1
-
Breast neoplasm (1)
-
-
1
Fanconi anemia complementation group D1 (1)
-
-
1
Medulloblastoma;C0346153:Familial cancer of breast;C0376358:Prostate cancer;C1838457:Fanconi anemia complementation group D1;C2675520:Breast-ovarian cancer, familial, susceptibility to, 2;C2751641:Glioma susceptibility 3;C3150546:Pancreatic cancer, susceptibility to, 2;CN033288:Wilms tumor 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.21
CADD
Benign
22
DANN
Benign
0.97
Eigen
Uncertain
0.34
Eigen_PC
Uncertain
0.27
FATHMM_MKL
Benign
0.73
D
MetaRNN
Benign
0.0060
T
MetaSVM
Benign
-0.79
T
PhyloP100
1.1
PrimateAI
Benign
0.45
T
PROVEAN
Benign
-1.1
N
REVEL
Benign
0.27
Sift
Uncertain
0.0020
D
Sift4G
Uncertain
0.0080
D
Vest4
0.43
MVP
0.81
MPC
0.17
ClinPred
0.033
T
GERP RS
1.7
gMVP
0.45
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4987047; hg19: chr13-32953529; COSMIC: COSV104701290; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.